Acute injury in the peripheral nervous system triggers an alternative macrophage response by Ydens, Elke et al.
JOURNAL OF 
NEUROINFLAMMATION
Ydens et al. Journal of Neuroinflammation 2012, 9:176
http://www.jneuroinflammation.com/content/9/1/176RESEARCH Open AccessAcute injury in the peripheral nervous system
triggers an alternative macrophage response
Elke Ydens1, Anje Cauwels2,3, Bob Asselbergh1, Sofie Goethals1, Lieve Peeraer1, Guillaume Lornet3,4,
Leonardo Almeida-Souza1, Jo A Van Ginderachter5,6, Vincent Timmerman1* and Sophie Janssens3,4*Abstract
Background: The activation of the immune system in neurodegeneration has detrimental as well as beneficial
effects. Which aspects of this immune response aggravate the neurodegenerative breakdown and which stimulate
regeneration remains an open question. To unravel the neuroprotective aspects of the immune system we focused
on a model of acute peripheral nerve injury, in which the immune system was shown to be protective.
Methods: To determine the type of immune response triggered after axotomy of the sciatic nerve, a model for
Wallerian degeneration in the peripheral nervous system, we evaluated markers representing the two extremes of a
type I and type II immune response (classical vs. alternative) using real-time quantitative polymerase chain reaction
(RT-qPCR), western blot, and immunohistochemistry.
Results: Our results showed that acute peripheral nerve injury triggers an anti-inflammatory and
immunosuppressive response, rather than a pro-inflammatory response. This was reflected by the complete
absence of classical macrophage markers (iNOS, IFNγ, and IL12p40), and the strong up-regulation of tissue repair
markers (arginase-1, Ym1, and Trem2). The signal favoring the alternative macrophage environment was induced
immediately after nerve damage and appeared to be established within the nerve, well before the infiltration of
macrophages. In addition, negative regulators of the innate immune response, as well as the anti-inflammatory
cytokine IL-10 were induced. The strict regulation of the immune system dampens the potential tissue damaging
effects of an over-activated response.
Conclusions: We here demonstrate that acute peripheral nerve injury triggers an inherent protective environment
by inducing the M2 phenotype of macrophages and the expression of arginase-1. We believe that the M2
phenotype, associated with a sterile inflammatory response and tissue repair, might explain their neuroprotective
capacity. As such, shifting the neurodegeneration-induced immune responses towards an M2/Th2 response could
be an important therapeutic strategy.
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Injury to the peripheral nervous system (PNS) induces a
well-orchestrated cellular process that leads to the
complete disintegration of the nerve segment distal to
the lesion site, termed Wallerian degeneration (WD) [1].* Correspondence: vincent.timmerman@molgen.vib-ua.be; sophie.janssens@
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reproduction in any medium, provided the orAs axons are disconnected from their cell bodies, they
are rapidly fragmented by an intrinsic active process of
self-destruction [2]. Due to the loss of axonal contact,
the myelinating Schwann cells (SC) dedifferentiate into
an immature phenotype, start proliferating, and help in
the degeneration of myelin. Wallerian degeneration typ-
ically triggers a strong neuroinflammatory response in
which the SCs are believed to play an important role.
Being in close contact with the nerves, SCs are among
the first to respond to nerve damage. They induce the
production of pro-inflammatory cytokines such as TNF,
IL-1α, and IL-1β within hours after nerve injury [3-5].td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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additional immune mediators such as IL-6, GM-CSF,
and IL-10 in both Schwann cells and fibroblasts
[3,4,6,7]. The production of MCP-1 and MIP-1α, which
reaches a maximum at 1 day after injury, promotes the
recruitment of macrophages to the damaged nerves
[4,8]. Moreover, mast cells accumulate in the endoneur-
ium of injured nerves [9] and release mediators that
contribute to the recruitment of macrophages and neu-
trophils [9,10]. Infiltration of blood-borne monocytes,
which spread over the entire nerve, starts from 2 to
3 days after injury and macrophage accumulation peaks
at 7 days post injury [11-14]. These infiltrated immune
cells take over the cytokine production and are respon-
sible for the rapid clearance of myelin debris. Before the
infiltration of hematogenous macrophages, local macro-
phages proliferate and undergo morphological changes
consistent with immunophenotypic signs of activation
[15]. These resident macrophages, together with SCs,
readily contribute to myelin phagocytosis [12,16]. Two
to three weeks after injury, the inflammatory response is
turned off and macrophages are rapidly eliminated
[12,13,17]. Generally, WD is believed to induce a strong
pro-inflammatory response, as reflected by the induction
of cytokines such as TNF and IFNγ [18-20], and the
reported elevation of iNOS [21]. Still, one would expect
that neurodegeneration might trigger a more dampened
immune response, which is typically associated with
sterile inflammation. To address this question we used a
model of WD (axotomy of the sciatic nerve) to analyze
which type of immune response is being induced. Our
results revealed that WD leads to the expression of sev-
eral negative regulators of the innate immune system. In
addition, a predominant M2-like macrophage response
could be observed, reflecting the presence of an im-
munosuppressive milieu necessary to initiate wound re-
pair and restore tissue homeostasis.
Material and methods
Mice work and induction of peripheral nerve injury
All animal experiments were approved by the local
ethics committee (University of Antwerp), and con-
ducted according to the guidelines of the Federation of
European Laboratory Animal Science Associations
(FELASA). Axotomy experiments of the N. ischiadicus
(sciatic nerve) were conducted in 6- to 8-week-old
C57BL/6 mice as previously described [22]. Briefly,
mice were anesthetized with a single intraperitoneal in-
jection of ketamine (Ketalar; Pfizer; 150 mg kg-1) and
xylazine (Rompun; Bayer; 10 mg kg-1). An incision was
made at the right thigh, and gluteal and hamstring
muscles were carefully separated to expose the sciatic
nerve. The sciatic nerve was transected and the wound
was closed by sutures. The contralateral side was leftuntouched. For analgesia, bupronorphinum (Temgesic;
Schering-Slough; 0,1 mg kg-1) was injected after surgery.
Sham operation experiments were performed to evaluate
the effect of damage around the nerve, inflicted by the
operation, on the gene expression profile.
Intravenous injection of TLR ligands
Lipopolysaccharide (LPS; TLR4-ligand) (Sigma; 10 mg kg-1)
or triacyl lipopeptide (Pam3Cys; TLR1/2-ligand) (Sigma;
10 mg kg-1) were injected intravenously in 6- to 8-week-old
C57BL/6 mice. PBS was injected in the control mice.
RNA isolation and RT-qPCR
At defined time points after sciatic nerve transection,
the mice were euthanized by inhalation of CO2. The dis-
tal part of the transected N. ischiadicus and the contra-
lateral control side were removed; snap frozen and
stored at −80 °C until use. The nerves were homoge-
nized in Trizol with a Potter Elvehjem homogenisator,
and small fragments were further homogenized by sonic-
ation. Total RNA was extracted using the RNeasy Lipid
Tissue kit (Qiagen) according to the manufacturer’s
protocol. The quality of the RNA was verified by gel
electrophoresis. DNase treatment was performed with
TURBO DNase (Ambion). cDNA was produced using
the Superscript III first strand synthesis system for RT-
PCR (Invitrogen). Real-time quantitative polymerase
chain (RT-qPCR) reactions were done with 10 ng cDNA
in SYBR Green I mix and run on an ABI Prism 7900 HT
Sequence Detection System (Applied Biosystems). All
PCR reactions were performed in triplicate. Primers
were designed making use of Primerbank (www.pga.
mgh.harvard.edu/primerbank). Primer sequences are
listed in Table 1. The RT-qPCR data were normalized
according to the method described by Vandesompele et
al. [23], by geometric averaging of multiple internal con-
trol genes. Processing the raw data and normalization of
the relative quantities were computed with an improved
version of the ΔΔ-Ct-method [24]. The mRNA expres-
sion levels are expressed relative to the basal condition
(0 h time point; not operated mice or not injected mice).
Cell isolation
As a control for the western blot analysis, peritoneal
macrophages were stimulated to induce the M1 or M2
expression profile. Peritoneal macrophages were isolated
from adult mice that were injected with 3 % thioglycol-
late [25]. On day 4 after injection, mice were euthanized
and the peritoneal cavity rinsed with ice-cold PBS.
Macrophages were collected and resuspended in RPMI
with 1 % FCS. Erythrocytes stayed in suspension and
were removed after 45 min. The remaining cells were
kept in RPMI with 10 % FCS. The next day, dendritic
cells in suspension were removed and macrophages were
Table 1 Primer sequences
Negative regulators
A20 GAACAGCGATCAGGCCAGG GGACAGTTGGGTGTCTCACATT
IκBα TGAAGGACGAGGAGTACGAGC TTCGTGGATGATTGCCAAGTG
IL-1RA GCTCATTGCTGGGTACTTACAA CCAGACTTGGCACAAGACAGG
MyD88s TGAAGTCGCGCATCGGAC CGGCGACACCTTTTCTCAAT
SIGIRR GTGACATGGCCCCTAATTTCC ATGCCAGACCATCTTTCAGCC
SOCS1 CTGCGGCTTCTATTGGGGAC AAAAGGCAGTCGAAGGTCTCG
Immune mediators
Cox2 TGAGCAACTATTCCAAACCAGC GCACGTAGTCTTCGATCACTATC
MIP-1α TTCTCTGTACCATGACACTCTGC CGTGGAATCTTCCGGCTGTAG
IL1β GCAACTGTTCCTGAACTCAACT ATCTTTTGGGGTCCGTCAACT
IL6 TAGTCCTTCCTACCCCAATTTCC TTGGTCCTTAGCCACTCCTTC
MCP-1 TTAAAAACCTGGATCGGAACCAA GCATTAGCTTCAGATTTACGGGT
Macrophage markers and M1/M2 markers
AIF1/Iba1 ATCAACAAGCAATTCCTCGATGA CAGCATTCGCTTCAAGGACATA
Arg1 TGGCTTGCGAGACGTAGAC GCTCAGGTGAATCGGCCTTTT
CD11b CCATGACCTTCCAAGAGAATGC ACCGGCTTGTGCTGTAGTC
Cdh1 GTCTACCAAAGTGACGCTGAA GGGTACACGCTGGGAAACAT
F4/80 ATGGACAAACCAACTTTCAAGGC GCAGACTGAGTTAGGACCACAA
FIZZ1 CCAATCCAGCTAACTATCCCTCC ACCCAGTAGCAGTCATCCCA
IFNγ ATGAACGCTACACACTGCATC CCATCCTTTTGCCAGTTCCTC
IL4 GGTCTCAACCCCCAGCTAGT GCCGATGATCTCTCTCAAGTGAT
IL10 ATGGCCGGATAGCCTTATTC ACGATGTGGTGACAACCGTA
IL12p40 AGTGTGAAGCACCAAATTACTCC CCCGAGAGTCAGGGGAACT
IL-13 GCAACATCACACAAGACCAGA GTCAAGGAATCCAGGGCTAC
iNOS GTTCTCAGCCCAACAATACAAGA GTGGACGGGTCGATGTCAC
MRC1 CTCTGTTCAGCTATTGGACGC CGGAATTTCTGGGATTCAGCTTC
TREM2 GAACCGTCACCATCACTCTGA CCTCGAAACTCGATGACTCCT
Ym1 AGAAGGGAGTTTCAAACCTGGT CTCTTGCTGATGTGTGTAAGTGA
IFNγR1 GTGGAGCTTTGACGAGCACT ATTCCCAGCATACGACAGGGT
IL4Rα ATTTTGCTGTTGGTGACTGGA CGTGGAAGTGCGGATGTAGT
IL10R CCTATCCCAAACCAGTCTGAGA CCAGGTTGAGTTTCCGTACTGT
IL13Rα1 TCAGCCACCTGTGACGAATTT TGAGAGTGCAATTTGGACTGG
Scavenger receptors
Clec7a ATTTTGGCGACACAATTCAGGG GCAAGACTGAGAAAAACCTCCT
Rage ATGCACAGAAACGGGATCTTT CTGCTTGGAATAGACACTCCG
Housekeeping genes
ACTB GCTTCTAGGCGGACTGTTACTGA GCCATGCCAATGTTGTCTCTTAT
B2M ATGCACGCAGAAAGAAATAGCAA AGCTATCTAGGATATTTCCAATTTTTGAA
HMBS GAAACTCTGCTTCGCTGCATT TGCCCATCTTTCATCACTGTATG
RPL13a CCTGCTGCTCTCAAGGTTGTT TGGTTGTCACTGCCTGGTACTT
TBP TCTACCGTGAATCTTGGCTGTAAA TTCTCATGATGACTGCAGCAAA
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were stimulated with either LPS (Sigma; 100 ng ml-1)
and IFNγ (R&D Systems; 100 ng ml-1) or IL-4 (R&D Sys-
tems; 10 ng ml-1) and IL-13 (R&D Systems; 10 ng ml-1)
to generate M1 or M2 macrophages, respectively.
Western blot analysis
For western blot analysis, the distal part of the trans-
ected N. ischiadicus and the contralateral control side
were carefully removed; snap frozen and stored at −80 °
C until use. Protein lysates were prepared in E1A lysis
buffer (1 % NP-40, 20 mM HEPES (pH 7.9), 250 mM
NaCl, 20 mM β-glycerophosphate, 10 mM NaF, 1 mMFigure 1 Peripheral nerve injury triggers a transient immune respons
mediators at different time points after peripheral nerve injury (a), and the
determined by RT-qPCR analysis. RT-qPCR data are analyzed using the ΔΔ-
basal condition (=0 h time point). Data presented are the compiled data o
of independent experiments for each gene.sodium orthovanadate, 2 mM dithiothreitol, 1 mM
EDTA, and a protease inhibitor cocktail) by homoge-
nization in a Potter Elvehjem homogenisator. Total pro-
tein concentration was determined by Bradford. Equal
amounts of protein lysates (20 to 30 μgram) were sepa-
rated on NuPAGE gels, transferred to nitrocellulose
membranes and analyzed by immunoblotting. Briefly,
membranes were blocked using blocking buffer (5 %
milk in PBS containing 0.1 % Tween-20), and incubated
overnight at 4 °C with a primary antibody. Secondary
HRP-conjugated antibodies were used to visualize anti-
body signals on films using the ECL system (Thermo
Scientific). Antibodies used were anti-arginase-1 (Santae. RT-qPCR analysis showing the transient induction of immune
induction of negative regulators of the innate immune response (b), as
Ct method and mRNA expression levels are expressed relative to the
f different independent experiments, with n representing the number
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ies; 1/1,000) and anti-β-tubulin (Abcam; 1/10,000).
Immunohistochemistry
The dissected distal part of the sciatic nerve was fixed
overnight in Bouin’s fixative (saturated picric acid, for-
maldehyde, and glacial acetic acid). The nerves were
dehydrated, embedded in paraffin for longitudinal sec-
tioning, and stored until processing. The 4 μm sections
were immunohistochemically stained using the avidin-
biotin staining technique. Briefly, slides were rehydrated
and antigen retrieval was performed by boiling the slides
in a citrate buffer (0.1 M sodium citrate buffer; pH 6.0).
Endogenous peroxidase activity was blocked by treating
the slides with 2 % hydrogen peroxide for 20 min. Next,
the slides were incubated for 30 min in blocking buffer
(20 % normal goat serum in PBS with 1 % BSA) and
incubated overnight with primary antibody at 4 °C. The
antibodies used were arginase-1 (Santa Cruz) and iNOS
(BD Transduction Laboratories). Sections were treated
with avidin-conjugated secondary antibodies for 30 min
at room temperature before adding an avidin-biotin
complex solution (Vector Laboratories) for 30 min.
The signal was visualized by incubating the sections
with 3.3’-diaminobenzidine (DAB) in PBS containing
0.1 % hydrogen peroxide. Negative control sections
were handled the same way, but in the absence of pri-
mary antibody. All sections were counterstained with
hematoxylin and dehydrated before mounting. Sections
were analyzed with a standard light microscope (ZeissTable 2 Overview of the main functions of immune mediator
Immune mediators
MCP-1 (CCL2) Monocyte chemoattractant
protein- 1 (CC-chemokine 2)
COX2 Cyclo-oxygenase 2
IL-1β Interleukin-1 beta
IL-6 Interleukin 6
MIP-1α (CCL3) Macrophage inflammatory
protein 1 alpha (CC-chemokine 3)
Negative regulators
A20 -
IκBα Inhibitor kappa B alpha
IL-1RA IL-1 receptor antagonist
MyD88s Myeloid differentiation 88 small
SIGIRR Single immunoglobulin
IL-1R-related molecule
SOCS1 Suppressor of cytokine signaling 1Axioskop with Olympus UC30 camera). For double im-
munofluorescence staining, the 4 μm sections of
paraffin-embedded sciatic nerves, which were processed
for antigen retrieval as described above, were incubated
in a blocking solution (1 % milk in PBS) for 30 min
and incubated at 4 °C with goat-anti-arginase-1 anti-
body (Santa Cruz). The next day, a donkey-anti-goat
Alexa fluor 488 conjugated secondary antibody (Life
Technologies) was applied. After stringent washing, the
staining with the second marker was performed with
the same procedure, using a marker for macrophages
(F4/80; Santa Cruz) and a marker for Schwann cells
(S100; Dako) and an Alexa fluor 594 conjugated sec-
ondary antibody (Life Technologies). Negative controls,
excluding one or both of the primary antibodies, were
included in the experiments. The immunofluorescence
images were captured on a Zeiss LSM700 confocal
microscope, using a 40× (1.3 NA) objective. Frame-by-
frame scanning with standard emission settings and ex-
citation with a 488 nm or 555 nm diode laser was used
to discriminate the two fluorophores.
Results
Wallerian degeneration (WD) induces an immune re-
sponse that is considered to be predominantly pro-
inflammatory by expressing several pro-inflammatory
molecules such as TNF, IFNγ, and iNOS [19-21]. To
confirm the pro-inflammatory environment, we isolated
total RNA of the distal segment of four sciatic nerves
isolated at different time points upon axotomy. Wes and negative regulators of the immune system
Chemokine, emigration of monocytes from
bone marrow; monocyte recruitment [27]
Production of prostaglandins; vasodilatation,
inflammation, platelet disaggregation [28], neuropathic pain [29]
Pro-inflammatory cytokine; many biological functions:
up-regulation of adhesion molecules, influx of neutrophils,
induction of additional inflammatory mediators,
important in sterile inflammation [30]
Pleiotropic cytokine; wide range of biological activities in
immune regulation, hematopoiesis, and inflammation [31]
Chemokine, recruitment of monocytes to the inflamed tissue [4]
Negative regulator of TLR-signaling. Blocks TLR-mediated
signaling by blocking NFκB signaling [32]
Inhibits NFκB signaling by masking the nuclear localization
signal, keeping NFκB in its inactive state [33]
Antagonist of IL-1; binds to IL-1R1 thereby blocking signaling [30]
Antagonist of the adaptor protein MyD88 [26]
Inhibits IL-1 signaling, orphan receptor of IL-1 family with
antagonistic properties [34]
Suppression of cytokine signaling by inhibiting JAK tyrosine kinase [35]
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the expression of several cytokine and chemokine tran-
scripts using RT-qPCR. In line with literature data, the
inflammatory mediators IL-1β, Cox2, MCP-1, and MIP-
1α were strongly up-regulated, with maximum expres-
sion levels at 24 h after axotomy (Figure 1a) [4]. Strik-
ingly, the expression levels of the inflammatory genes
dropped at later time points after axotomy, with most
pro-inflammatory genes returning to the basal condition
at 48 h. We determined whether this transient immune
response was accompanied with the induction of several
negative regulators of the immune system and found
that IL-1RA displayed a high induction (Figure 1b).
Moreover, MyD88small (MyD88s) and IκBα, both nega-
tively regulating NF-κB activation [26], were up-
regulated already 4 h after injury. In contrast, two other
negative regulators of the NF-κB pathway, A20 and
SIGIRR, were not induced. Suppressor of cytokineTable 3 Overview of the main functions of M1 and M2 associ
General macrophage markers
CD11b Cluster of differentiation 11b
F4/80 (EMR1) EGF-like module-containing mucin-like hormone receptor-li
Iba1 Ionized calcium binding adaptor molecule 1
M1 associated markers
IFNγ Interferon gamma
IL-12p40 Interleukin 12 subunit p40
iNOS Inducible nitric oxide synthase
M2 associated markers
Arg1 Arginase 1
CDH1 Cadherin-1
Clec7a (dectin1) C-type lectin domain family 7, member a
FIZZ1 Found in inflammatory zone
IL-4 Interleukin 4
IL-10 Interleukin 10
IL-13 Interleukin 13
MRC1 Mannose receptor type C1
Rage Receptor for advanced glycosylation end products
Trem2 Triggering receptor expressed on myeloid cells 2
Ym1 (CH3L3) Chitinase 3-like-3signaling 1 (SOCS1) was only weakly induced after axot-
omy at these early time points (Figure 1b). Functions of
the immune mediators and negative regulators are
shown in Table 2.
While many reports already described the induction of
cytokines and chemokines in WD, it is less obvious what
type of immune response is triggered by injury in the
PNS. Therefore, we decided to focus on gene expression
profiles for genes associated with M1 vs. M2 macro-
phages, representative for the two extremes of a merely
pro-inflammatory vs. a merely anti-inflammatory/wound
healing phenotype [25,36,37]. The main functions of
these genes are described in Table 3. We first deter-
mined when macrophages start to accumulate in our
model, by analyzing the presence of three universal mar-
kers for macrophages (Iba1, CD11b, and F4/80) using
RT-qPCR [38,39]. In general, it is considered that a first
contribution to the immune response in the nerve isated markers
Expressed on all myeloid lineage cells
ke 1 Expressed on most tissue macrophages
Expressed on macrophages (and microglia)
Polarize macrophages towards M1; critical for innate
and adaptive immunity against viral and intracellular
bacterial infections (also produced by macrophages) [40]
Pro-inflammatory cytokine; induces Th1[41], production
of cytokines (mainly IFNγ) [42], stimulation cell-mediated
immunity against microbial pathogens [43]
Production of nitric oxide (NO) using arginine as a substrate;
defense against microorganisms [44]
Production of L-ornithine and urea using arginine as a substrate,
first step to production of polyamines (growth factors in the
nervous system) [45]; counteracts iNOS
Cell-cell adhesion [46], interaction with CD103 of regulatory
T-cells [47]
Pattern recognition; non-opsonic beta-glucan receptor [48]
Lipid and sugar metabolism; angiogenesis-promoting factor [49]
Th2 effector cytokine: polarize macrophages to M2 [50]; IgE class
switching, differentiation of CD4+ T-cells into Th2 cells [51]
Anti-inflammatory cytokine [52]
Th2 effector cytokine: polarize macrophages to M2; fibrosis; defense
against parasite infections [53]
Pattern recognition, type II response promoting effect [54]
Pattern recognition; binds endogenous ligands such as S100B to
stimulate trophic effects on neurons [55]
Pattern recognition [56]; augmentation of apoptotic neuron
phagocytosis and attenuation of proinflammatory cytokine
secretion [57]
Weak eosinophils chemoattractant properties [58]; binds heparan
sulfate, heparin, GlcN olimers; Th2 promoting effect [59]
Figure 2 (See legend on next page.)
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Figure 2 Peripheral nerve injury induces M2 associated genes. RT-qPCR analysis of the immune response up to 14 days post injury, showing
macrophage markers (a), cytokine expression (b), M1 associated genes (c), and M2 associated markers (d). Sham operation induces M2 markers,
but only to a minor extent compared to acute neurodegeneration (e). The mRNA levels are expressed relative to the basal condition (=0 h time
point). Data presented are the compiled data of different independent experiments, with n representing the number of independent
experiments for each gene. For sham operation one representative experiment out of two independent experiments is shown.
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dent macrophages, and fibroblasts) because blood-borne
monocytes infiltrate the nerve only 2 to 3 days after in-
jury [12]. Macrophages, expressing Iba1, CD11b, and F4/
80, start to accumulate in the injured nerves from day 3
onwards as determined by RT-qPCR (Figure 2a) and
immunohistochemistry (Figure 3). Coinciding with the
accumulation of macrophages, a second peak in the im-
mune response could be observed, as shown by the bi-
phasic induction of IL-6 and IL-1β expression
(Figure 2b). As expected, MCP-1, a chemoattractant for
macrophages produced by Schwann cells, is expressed
right before macrophage accumulation (Figure 2b). In
order to determine the phenotype of the macrophages
present in the peripheral nerve after injury, we analyzed
markers typically associated with M1 vs. M2 macro-
phages. None of the M1 markers such as iNOS, IL-
12p40, and IFNγ were induced after axotomy at any
time point investigated (Figure 2c). On the other hand,
the M2-associated genes, arginase-1 and Ym1, were
clearly induced. The expression of these genes reached a
maximum at 1 day after axotomy and returned to basal
level at day 7. Another typical marker for M2 macro-
phages, Trem2, was induced from day 3 onwards and its
expression level remained elevated till day 14 after axot-
omy (the latest time point investigated in this study)
(Figure 2d). The expression of Trem2 appeared to be
mediated by the accumulating macrophages, as its ex-
pression level displayed a similar pattern as the general
macrophage markers (Figure 2b and d). Some markers
(arginase-1 and Ym1) were also slightly induced in
sham-operated animals, however this induction was only
minor compared to the induction seen after axotomy
(Figure 2e). Altogether, these data suggest that acute per-
ipheral nerve injury favors an M2 macrophage environ-
ment. Additional analyses confirmed this hypothesis. We
found that receptors known to trigger M2 cells (such as
IL-4Rα and IL-13Rα1), and to stimulate macrophage
suppressor function (such as IL-10R), were induced in
injured peripheral nerves at 7 and 14 days after injury
(Figure 4a). The IFNγR1 receptor, which characterizes
M1 macrophages, was not enhanced (Figure 4b). More-
over, scavenger receptors (such as Clec7a and Rage),
which are typically expressed by M2 macrophages,
showed an increased expression level after axotomy at
the late time points relative to the uninjured control
nerve (Figure 4c).The M2 gene expression profile is typically triggered
by the cytokines IL-4 and/or IL-13 [60]. In order to de-
termine if these cytokines play a role in the induction of
the alternative macrophage environment after axotomy,
their expression level was investigated at early time
points using RT-qPCR. The IL-4 expression was hardly
detectable at the mRNA level in our model of acute per-
ipheral nerve injury and did not seem to be induced.
The IL-13 expression, however, was induced upon axot-
omy at the earliest time point (4 h) investigated
(Figure 4d). Importantly, also the anti-inflammatory
cytokine IL-10 was induced after injury (Figure 4d). The
high IL-10 and low IL-12p40 expression levels are repre-
sentative of a typical M2 activation profile (Figures 2c
and 4d).
Next we analyzed the macrophage phenotype at pro-
tein level by using western blot and immunohistochem-
istry. As the balance between arginase-1 and iNOS
expression is highly indicative of the macrophage pheno-
type, these two markers were used in the following
experiments [36]. Western blot analysis of protein
lysates of the distal segment of the sciatic nerve showed
an induction of arginase-1 protein after axotomy.
Arginase-1 protein was detectable from day 1 after in-
jury and reached a maximal signal at day 3. Albeit show-
ing a small decrease over time, the arginase-1 protein
level remained high until day 14 after axotomy
(Figure 5a). iNOS was not detectable at any time point
by western blot analysis, confirming our RT-qPCR data
(Figure 5b). As a positive control, peritoneal macro-
phages were stimulated in vitro with either IL-4/IL-13 or
LPS/IFNγ to obtain M2 and M1 macrophages, respect-
ively. As expected, the M2 macrophages expressed
arginase-1 and the M1 macrophages expressed iNOS
protein (Figure 5a, b). Immunohistochemistry of
paraffin-embedded sciatic nerves confirmed the tem-
poral expression profile for arginase-1 shown by western
blot. Arginase-1 is rapidly expressed throughout the en-
tire injured nerve. The expression level peaked at 3 days
post injury and remained high until day 14 (Figure 5c).
Double immunofluorescence staining revealed that
arginase-1 was present in F4/80 positive cells and not in
S100 positive Schwann cells, which identifies macro-
phages as the main source for arginase-1 (Figure 6).
While at earlier time points all cells that expressed F4/
80 were found to be positive for arginase-1, at later time
points arginase-1 negative macrophages were present as
Figure 3 Accumulation of macrophages in the injured sciatic
nerve. Immunohistochemical staining of sciatic nerve slices for F4/
80 at different time points after injury. Scale bar 50 μm.
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that this protein was not induced after axotomy
(Figure 5c). We only observed strong iNOS staining in
blood capillaries in particular regions on the nerve that
was present independently of the axotomy, showing that
the antibody staining was working properly (Figure 5d).
Finally, we determined whether the M2-predominated
immune response triggered after nerve injury is typical for
the PNS or whether it is specific for neurodegeneration.
To this end, we investigated at different time points the
expression of M1 and M2 markers in sciatic nerves from
mice intravenously injected with TLR-ligands. We used
lipopolysaccharide (LPS), a TLR4 ligand known to induce
a classical type I immune response, and Pam3Cys, a
TLR1/2 ligand. Intravenous injection of LPS as well as
Pam3Cys elicited a rapid and strong immune response in
the sciatic nerve, as shown by the induction of inflamma-
tory genes such as IL-1β, Cox2, MIP-1α, and MCP-1
(Figure 7a). Interestingly, the pro-inflammatory cytokine
IL-12p40 and typical M1 immune mediator iNOS, both
representative for a type I immune response, were induced
after LPS injection (Figure 7b). Several negative regulators,
such as IL-1RA, MyD88s, and SOCS1, which mediate a
negative feedback loop, were also induced by LPS injec-
tion (Figure 7c). Injection with Pam3Cys, however, clearly
induced a mixed immune response as reflected by the ex-
pression of the M1 associated cytokine IL-12p40 and the
expression of Ym1, which is an M2-associated macro-
phage marker (Figure 7b). iNOS was not detectable after
Pam3Cys injection (Figure 7b) and none of the other M2-
associated genes such as arginase-1 and Trem2 were
induced (Figure 7b). These data show that a prototypical
type I immune response can be observed in the nerve
after injection of LPS, while Pam3Cys seems to induce a
mixed immune response. Both TLR-mediated responses
clearly differed from the immune response induced after
acute peripheral nerve injury.
Discussion
In response to an infection, a strong pro-inflammatory
immune response is triggered. The recruited inflamma-
tory cells are activated when they encounter pathogen-
associated molecular products (PAMPs) such as LPS.
Hereupon, these cells phagocytose infectious agents and
produce pro-inflammatory mediators such as iNOS, IL-
12, ROS, and RNS to fight off the invading pathogen.
These agents, however, can also cause tissue damage.
The innate immune system also detects the presence of
endogenous molecules; so-called danger associated mo-
lecular patterns (DAMPs) that are only exposed in condi-
tions of injury. Under conditions of cellular stress or
injury, one might expect a more dampened, strictly con-
trolled immune response as the cost-benefit ratio is
higher. As we and others have shown, pro-inflammatory
Figure 4 Peripheral nerve injury is associated with the expression of M2-associated cytokines and cytokine receptors. RT-qPCR analysis
of the sciatic nerve showing cytokine receptor expression profiles upon injury (a, b), scavenger receptor expression (c), and expression of M2
cytokines (d). The mRNA levels are expressed relative to the basal condition (=0 h time point). Data presented are the compiled data of different
independent experiments, with n representing the number of independent experiments for each gene.
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as MIP-1α and MCP-1 are rapidly induced in WD, a
model of sterile inflammation in the nerve [3,4]. In the
present study we show that the expression of these in-
flammatory genes is strictly controlled as the mRNA
levels of all cytokines and chemokines return to basal
level at 48 h. Negative regulators of the pro-
inflammatory signaling pathways are induced prior to the
decline in inflammatory gene expression, thereby limiting
the pro-inflammatory immune response and also the ex-
cessive damage caused by the immune system.
Although PAMPs and DAMPs are recognized by the
same set of receptors, such as TLRs, they can induce a dif-
ferent set of genes [61]. Bacterial compounds trigger a
microbicidal environment and classically activated M1
macrophages; while endogenous molecules seem to acti-
vate an inflammatory response associated with genes
that mediate tissue repair [61,62]. Since most studies
so far focused specifically on the induction of pro-
inflammatory mediators, WD in the PNS has always
been associated with the induction of a strong pro-
inflammatory immune response. We found, however,by analyzing genes associated with M1 and M2 macro-
phages, that acute peripheral nerve injury rather
induces an M2-like macrophage environment. None of
the typical pro-inflammatory markers of the M1 sub-
type of macrophages such as iNOS, IFNγ, and IL-
12p40 could be detected, while M2 markers such as
arginase-1, Ym1, and Trem2 were highly up-regulated.
Intriguingly, other M2 markers like Fizz1 and Cdh1
were not induced. Van den Bossche et al. showed that
some M2 markers like Cdh1 are strongly down-
regulated by the presence of pro-inflammatory cyto-
kines [63]. This could be the case here as well. The
stimulation of the alternative macrophage environment
in the nerve appeared to be controlled at the level of
IL-13. This cytokine was readily detectable from 4 h
after the onset of neurodegeneration, and prior to the
expression of arginase-1 and Ym1. IL-13, which is to-
gether with IL-4 a central master switch in the M2
phenotype, is typically expressed by macrophages, baso-
phils, mast cells, or activated T cells [64]. Since we de-
tect accumulation of macrophages only from days 2 to
3 onwards, it is less clear at the moment which cells
Figure 5 Protein analysis of M1 versus M2 markers after PNS injury. Western blot analysis showing the arginase-1 protein induction in
axotomized sciatic nerves. The IL-4/IL-13 stimulated peritoneal macrophages were used as a positive control (M2) (a). Western blot analysis
showing iNOS protein induction in axotomized sciatic nerves. Peritoneal macrophages stimulated with IFNγ/LPS served as a positive control (M1)
(b). For western blot analysis, MW values expressed in kDa are shown at the right side of the blots. Immunohistochemical staining of sciatic nerve
slices for arginase-1 and iNOS at different time points after injury (c). Blood vessels in the nerves stain positive for iNOS by immunohistochemical
staining (d). Scale bar 50 μm.
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Figure 6 Arginase-1 positive cells in the injured peripheral nerve tissue are macrophages. Double immunofluorescently stained peripheral
nerve sections at day 0, day 1, day 3, and day 14 upon axotomy showing arginase-1 colocalizing with F4/80, a general macrophage marker. F4/
80, red; S100, red; arginase-1, green. Scale bar 20 μm.
Ydens et al. Journal of Neuroinflammation 2012, 9:176 Page 12 of 17
http://www.jneuroinflammation.com/content/9/1/176are responsible for the early onset expression of IL-13,
arginase-1, or Ym1. In the peripheral nerve resident
macrophages, mast cells or SCs could be engaged in
the expression of IL-13, while neutrophils could con-
tribute to the expression of arginase-1 and Ym1. Neu-
trophils are recruited to the damaged nerves at day 1
after injury [65], and are suggested to contribute to the
expression of tissue repair genes [66]. Our results dem-
onstrate that damage to the nerve establishes a rapid
immunosuppressive reaction within the nerve, and this
from very early time points on, which appears to be in
contrast with another recent report [67]. Shechter et
al. described that axotomy of the optic nerve creates a
pro-inflammatory environment in the nerve that was
later turned into an anti-inflammatory one by infiltrat-
ing macrophages [67]. Macrophages have been shown
before to play a beneficial role in WD in the PNS, as
depleting them impaired functional recovery [68]. By
phagocytosing debris, macrophages contribute to regen-
eration by removing inhibitory myelin debris and pav-
ing the way for neurite outgrowth. Pre-existing auto-
antibodies have been shown to play an important role
in clearance of myelin debris by promoting a macro-
phage influx and stimulating their phagocytic activity[69]. In addition, macrophages produce neurotrophic
factors, thereby supporting regeneration [70]. The pro-
tective role of macrophages in WD might also be
explained by their phenotype. The M2 macrophages
were shown to be neuroprotective in vitro by stimulat-
ing neurite outgrowth, while M1 macrophages were
neurotoxic to neuronal cell cultures [71]. Moreover, po-
tent inducers of a systemic Th2 switch, such as glatira-
mer acetate and statins, support the neuroprotection
and/or nerve regeneration [72-74]. The Th2-inducing
adjuvants, such as IFA and Alum, promote axon regen-
eration better than the Th1-inducing adjuvant CFA
[75,76]. Also Th2 cells support neuronal survival
in vitro to a greater extent than Th1 cells [77].
In autoimmune diseases of the PNS such as Guillian-
Barré Syndrome (GBS) and chronic inflammatory de-
myelinating polyneuropathy (CIDP), a Th1 response is
associated with the early stages of the disease. During re-
covery of GBS and CIDP, a shift towards a Th2 response
is observed, suggesting a protective role for Th2
responses in these diseases [78-80]. Also from animal
models it is apparent that type II immune responses are
beneficial; as nasal administration of recombinant IL-4
ameliorates ongoing experimental autoimmune neuritis
Figure 7 Immune response in the sciatic nerve of mice intravenously injected with TLRligands. Cytokine and chemokine induction in the
sciatic nerves after intravenous injection of LPS (TLR4 ligand) or Pam3Cys (TLR1/2 ligand). PBS injection was used as a negative control (a). M1-
and M2-associated gene expression after TLR ligand injection (b). Negative regulators are also induced upon LPS and Pam3Cys injection (c). Data
represented are the compiled data of two independent experiments.
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clinical course of GBS might be explained by the induc-
tion of IL-4 and IL-10. The role of the immune system in
hereditary neuropathies is less well studied. Patients suf-
fering from inherited neuropathies show endoneurial T-cells in their nerve biopsies and some patients even show
inflammatory infiltrates [82,83]. Studies with animal
models such as the heterozygote P0 mice, a model of
Charcot-Marie-Tooth (CMT) 1B neuropathy, clearly
show a functional degenerative role for macrophages and
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sponse triggered in hereditary neuropathies has not been
addressed.
In CNS injury, macrophages have been implicated in
both exacerbating as well as ameliorating tissue damage at
the injury site. Kigerl et al. showed that spinal cord injury
(SCI) initially induces both M1 and M2 macrophages,
however, the M1 phenotype predominates the lesion site
after 1 week [71]. The presence of both phenotypes might
explain the dual effect of macrophages in this model.
Moreover, axonal regeneration after SCI is prevented by
an inhibitory environment due to myelin inhibitors. Qui et
al. showed that elevating cAMP was sufficient to over-
come the myelin-mediated inhibition [86]. Subsequent
studies showed that arginase-1 and polyamines played a
major protective role downstream of cAMP [45]. By using
PNS grafts together with acidic fibroblast growth factor in
a model of SCI, the recruited macrophages produced large
amounts of arginase-1 and were involved in polyamine
synthesis [87]. This strategy significantly improved func-
tional recovery [88]. Altogether these data show a central
role for type II immune responses, arginase-1 and down-
stream polyamines in regeneration.
Lessons from graft implantation in CNS injury showed
that PNS tissue induces a permissive environment for
regeneration. Macrophages contribute to this permissive
environment as spinal cord-injured axons failed to re-
generate through peripheral nerve grafts in the absence
of CD11b+ cells [68]. We now hypothesize that PNS in-
jury triggers an inherent protective environment by in-
ducing an M2 phenotype of macrophages and arginase-1
expression. This model can further be used to unravel
how the environment is induced and to elucidate which
protective program needs to be elicited. Currently, it
remains to be shown how the alternative macrophage
environment is established; however there might be a
role for IL-13, a typical M2 inducer, as this cytokine is
up-regulated very early after injury and prior to the M2-
associated gene expression.
Finally, the induction of the alternative macrophage
environment appeared to be triggered specifically in re-
sponse to neurodegeneration. Our results show that
when challenged with bacterial products such as LPS, a
typical pro-inflammatory immune response, as reflected
by a strong IL-12p40 and iNOS signal and the absence
of Ym1 or arginase-1, could be detected within the PNS.
Intriguingly, injection with Pam3Cys, a TLR1/2 ligand,
induced a mixed response marked by presence of both
IL-12p40 and Ym1 induction. TLR2, the co-receptor for
TLR1, has been associated before with the induction of a
type II gene expression [89,90]. In a recent study we
showed that specifically TLR1 was highly induced after
acute peripheral nerve injury and hypothesized that it
might play a role in detecting neuronal injury [22]. Thepossible involvement of TLR1/2 in the detection of per-
ipheral nerve injury and in the switch towards the type
II gene expression is currently under investigation.
Conclusion
In conclusion, we demonstrate that acute peripheral
nerve injury induces an inherent protective response
with the initiation of several negative feedback loops,
limiting excessive tissue damage. Furthermore, we show
that an M2-like anti-inflammatory environment is
induced, rather than a pro-inflammatory one. Since type
II responses have been shown before to be neuroprotec-
tive, we believe that instead of inhibiting the immune
responses, shifting the macrophage phenotype or type of
immune response towards an alternative activation state
or type II response would be a better therapeutic strat-
egy to stimulate repair, as this would create a permissive
environment for neuronal regeneration.
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